Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Activity of simulated serum concentrations of daptomycin versus vancomycin during the first 24h of treatment in the presence of physiological albumin concentrations against vancomycin-susceptible, -tolerant or -intermediate-resistant Staphylococcus aureus.

Torrico M, Aguilar L, Sevillano D, Giménez MJ, Alou L, González N, Cafini F, Cleeland R, Prieto J.

Int J Antimicrob Agents. 2011 Apr;37(4):332-8. doi: 10.1016/j.ijantimicag.2010.12.007.

PMID:
21388792
2.

Bactericidal activity of daptomycin versus vancomycin in the presence of human albumin against vancomycin-susceptible but tolerant methicillin-resistant Staphylococcus aureus (MRSA) with daptomycin minimum inhibitory concentrations of 1-2microg/mL.

Torrico M, Giménez MJ, González N, Alou L, Sevillano D, Cafini F, Prieto J, Cleeland R, Aguilar L.

Int J Antimicrob Agents. 2010 Feb;35(2):131-7. doi: 10.1016/j.ijantimicag.2009.09.021. Epub 2009 Dec 16.

PMID:
20006469
3.

Comparative antimicrobial characterization of LBM415 (NVP PDF-713), a new peptide deformylase inhibitor of clinical importance.

Fritsche TR, Sader HS, Cleeland R, Jones RN.

Antimicrob Agents Chemother. 2005 Apr;49(4):1468-76.

4.

Pharmacokinetics of [18F]fleroxacin in patients with acute exacerbations of chronic bronchitis and complicated urinary tract infection studied by positron emission tomography.

Fischman AJ, Livni E, Babich JW, Alpert NM, Bonab A, Chodosh S, McGovern F, Kamitsuka P, Liu YY, Cleeland R, Prosser BL, Correia JA, Rubin RH.

Antimicrob Agents Chemother. 1996 Mar;40(3):659-64.

5.

Comparative evaluation of fleroxacin, ampicillin, trimethoprimsulfamethoxazole, and gentamicin as treatments of catheter-associated urinary tract infection in a rabbit model.

Morck DW, Lam K, McKay SG, Olson ME, Prosser B, Ellis BD, Cleeland R, Costerton JW.

Int J Antimicrob Agents. 1994 Jul;4 Suppl 2:S21-7.

PMID:
18611629
6.

Tissue pharmacokinetics of fleroxacin in humans as determined by positron emission tomography.

Rubin RH, Livni E, Babich J, Alpert NM, Liu YY, Cleeland R, Prosser BL, Thom E, Fischman AJ.

Int J Antimicrob Agents. 1994 Jul;4 Suppl 2:S15-20.

PMID:
18611628
7.

Pharmacokinetics of [18F]fleroxacin in healthy human subjects studied by using positron emission tomography.

Fischman AJ, Livni E, Babich J, Alpert NM, Liu YY, Thom E, Cleeland R, Prosser BL, Correia JA, Strauss HW, et al.

Antimicrob Agents Chemother. 1993 Oct;37(10):2144-52.

8.

Pharmacokinetics of fleroxacin as studied by positron emission tomography and [18F]fleroxacin.

Rubin RH, Livni E, Babich J, Alpert NM, Liu YY, Tham E, Prosser B, Cleeland R, Callahan RJ, Correia JA, et al.

Am J Med. 1993 Mar 22;94(3A):31S-37S.

PMID:
8452183
9.

Therapeutic efficacy of fleroxacin for eliminating catheter-associated urinary tract infection in a rabbit model.

Morck DW, Olson ME, McKay SG, Lam K, Prosser B, Cleeland R, Costerton JW.

Am J Med. 1993 Mar 22;94(3A):23S-30S.

PMID:
8452182
10.

Synthesis and biodistribution of 18F-labeled fleroxacin.

Livni E, Babich J, Alpert NM, Liu YY, Thom E, Cleeland R, Prosser BL, Correia JA, Strauss HW, Rubin RH, et al.

Nucl Med Biol. 1993 Jan;20(1):81-7.

PMID:
8461883
11.

General guidelines for clinical bacteriology. Infectious Diseases Society of America and the Food and Drug Administration.

Thrupp LD, Cleeland R, Jones RN, Novick WJ Jr, Reller LB, Thornsberry CL, Washington JA.

Clin Infect Dis. 1992 Nov;15 Suppl 1:S339-46.

PMID:
1477249
12.

Pharmacokinetics of 18F-labeled fleroxacin in rabbits with Escherichia coli infections, studied with positron emission tomography.

Fischman AJ, Livni E, Babich J, Alpert NM, Liu YY, Thom E, Cleeland R, Prosser BL, Callahan RJ, Correia JA, et al.

Antimicrob Agents Chemother. 1992 Oct;36(10):2286-92.

13.

In vitro activity of ceftriaxone and amikacin against Pseudomonas aeruginosa.

Prosser BL, Taylor DB, Cleeland R.

Chemotherapy. 1991;37(2):93-7.

PMID:
1903341
14.

Pharmacokinetics of Ro 23-9424, a dual-action cephalosporin, in animals.

Christenson JG, Chan KK, Cleeland R, Dix-Holzknecht B, Farrish HH Jr, Patel IH, Specian A.

Antimicrob Agents Chemother. 1990 Oct;34(10):1895-900.

15.

Cephalosporin 3'-quinolone esters with a dual mode of action.

Albrecht HA, Beskid G, Chan KK, Christenson JG, Cleeland R, Deitcher KH, Georgopapadakou NH, Keith DD, Pruess DL, Sepinwall J, et al.

J Med Chem. 1990 Jan;33(1):77-86.

PMID:
2153215
16.

In vivo evaluation of a dual-action antibacterial, Ro 23-9424, compared to cefotaxime and fleroxacin.

Beskid G, Siebelist J, McGarry CM, Cleeland R, Chan K, Keith DD.

Chemotherapy. 1990;36(2):109-16.

PMID:
2107064
17.

In vitro activities of a dual-action antibacterial agent, Ro 23-9424, and comparative agents.

Beskid G, Fallat V, Lipschitz ER, McGarry DH, Cleeland R, Chan K, Keith DD, Unowsky J.

Antimicrob Agents Chemother. 1989 Jul;33(7):1072-7.

18.

Mode of action of the dual-action cephalosporin Ro 23-9424.

Georgopapadakou NH, Bertasso A, Chan KK, Chapman JS, Cleeland R, Cummings LM, Dix BA, Keith DD.

Antimicrob Agents Chemother. 1989 Jul;33(7):1067-71.

19.

Amdinocillin treatment of catheter-associated bacteriuria in rabbits.

Olson ME, Nickel JC, Khoury AE, Morck DW, Cleeland R, Costerton JW.

J Infect Dis. 1989 Jun;159(6):1065-72.

PMID:
2656876
20.

Radiochemical method for evaluating the effect of antibiotics on Escherichia coli biofilms.

Dix BA, Cohen PS, Laux DC, Cleeland R.

Antimicrob Agents Chemother. 1988 May;32(5):770-2.

21.

Activity of antimicrobial agents against Staphylococcus epidermidis in established biofilms on latex catheter material and on titanium.

Taylor D, Prosser B, Cleeland R.

J Antimicrob Chemother. 1988 Apr;21(4):510-2. No abstract available.

PMID:
3378964
22.

Enteral, oral, and rectal absorption of ceftriaxone using glyceride enhancers.

Beskid G, Unowsky J, Behl CR, Siebelist J, Tossounian JL, McGarry CM, Shah NH, Cleeland R.

Chemotherapy. 1988;34(2):77-84.

PMID:
3391054
23.

Effect of medium chain glycerides on enteral and rectal absorption of beta-lactam and aminoglycoside antibiotics.

Unowsky J, Behl CR, Beskid G, Sattler J, Halpern J, Cleeland R.

Chemotherapy. 1988;34(4):272-6.

PMID:
3208545
24.

Method of evaluating effects of antibiotics on bacterial biofilm.

Prosser BL, Taylor D, Dix BA, Cleeland R.

Antimicrob Agents Chemother. 1987 Oct;31(10):1502-6.

25.

Collaborative clinical laboratory study of a broth-disk test for determination of bacterial susceptibility to beta-lactams in combination with amdinocillin.

Isenberg HD, Tilton RC, Barry AL, Beskid G, Cleeland R, Fallat V, Murray PR, Pierson C, Squires E.

J Clin Microbiol. 1987 Jul;25(7):1195-200. Erratum in: J Clin Microbiol 1987 Oct;25(10):2036.

26.

Antimicrobial activity of ceftriaxone: a review.

Cleeland R, Squires E.

Am J Med. 1984 Oct 19;77(4C):3-11. Review.

PMID:
6093515
27.

Interpretation of susceptibility testing of ceftriaxone.

Squires E, Cleeland R, Christenson J, Boehni E.

Am J Med. 1984 Oct 19;77(4C):12-6.

PMID:
6093512
28.

Morphologic changes produced by amdinocillin alone and in combination with beta-lactam antibiotics: in vitro and in vivo.

Kramer MJ, Mauriz YR, Timmes MD, Robertson TL, Cleeland R.

Am J Med. 1983 Aug 29;75(2A):30-41.

PMID:
6311003
29.

Enhanced activity of beta-lactam antibiotics with amdinocillin in vitro and and in vivo.

Cleeland R, Squires E.

Am J Med. 1983 Aug 29;75(2A):21-9.

PMID:
6311002
30.

Correlation of the results of antibiotic synergy and susceptibility testing in vitro with results in experimental mouse infections.

Isenberg HD, Sampson-Scherer J, Cleeland R, Titsworth E, Beskid G, Christenson JG, DeLorenzo WF, Unowsky J.

Crit Rev Microbiol. 1982;10(1):1-76. Review.

PMID:
6756787
31.

Mecillinam alone and in combination with ampicillin or moxalactam in experimental Escherichia coli meningitis.

Schaad UB, Grimm LM, Beskid G, Cleeland R, Nelson JD, McCracken GH Jr.

Infection. 1982;10(2):90-6.

PMID:
6284652
32.

In vivo activity of ceftriaxone (Ro 13-9904), a new broad-spectrum semisynthetic cephalosporin.

Beskid G, Christenson JG, Cleeland R, DeLorenzo W, Trown PW.

Antimicrob Agents Chemother. 1981 Aug;20(2):159-67.

33.

Comparative activity of mecillinam and ampicillin singly and in combination in the urinary bladder model and experimental mouse model.

Anderson JD, Eftekhar F, Cleeland R, Kramer MJ, Beskid G.

J Antimicrob Chemother. 1981 Aug;8(2):121-31. No abstract available.

PMID:
6268599
34.

Antibacterial activity of 2',3'-dideoxyadenosine in vivo and in vitro.

Beskid G, Eskin B, Cleeland R, Siebelist J, Cappetta A, Hill AD, Geiger RH.

Antimicrob Agents Chemother. 1981 Mar;19(3):424-8.

35.
36.

In vivo activity of amoxicillin and ampicillin against gram-positive bacteria: results of prophylactic studies.

Grunberg E, Cleeland R, Beskid G, DeLorenzo W.

J Infect Dis. 1978 Dec;138(6):872-6.

PMID:
33219
37.
38.

Detection of drugs of abuse by radioimmunoassay: a summary of published data and some new information.

Cleeland R, Christenson J, Usategui-Gomez M, Heveran J, Davis R, Grunberg E.

Clin Chem. 1976 Jun;22(6):712-25. Review.

PMID:
776447
39.

In vivo synergy between 6 beta-amidinopenicillanic acid derivatives and other antibiotics.

Grunberg E, Cleeland R, Beskid G, DeLorenzo WF.

Antimicrob Agents Chemother. 1976 Apr;9(4):589-94.

40.

Antiviral activity of 10-carboxymethyl-9-acridanone.

Kramer MJ, Cleeland R, Grunberg E.

Antimicrob Agents Chemother. 1976 Feb;9(2):233-8.

41.

Simultaneous detection of morphine and barbiturates in urine by radioimmunoassay.

Usategui-Gomez M, Heveran JE, Cleeland R, McGhee B, Telischak Z, Awdziej T, Grunberg E.

Clin Chem. 1975 Sep;21(10):1378-82.

42.

Mersalyl: a diuretic with antiviral properties.

Kramer MJ, Cleeland R, Grunberg E.

Antimicrob Agents Chemother. 1975 Sep;8(3):295-9.

43.

A simple, rapid 125I radioimmunoassay for the detection of barbiturates in biological fluids.

Cleeland R, Davis R, Heveran J, Grunberg E.

J Forensic Sci. 1975 Jan;20(1):45-57.

PMID:
1167900
44.

The in vivo and in vitro potentiation of sulfamethoxazole by trimethoprim against strains of Serratia marcescens.

Grunberg E, Beskid G, DeLorenzo WF, Cleeland R.

Int J Clin Pharmacol. 1973 Aug;8(1):47-50. No abstract available.

PMID:
4580383
45.

A sensitive, rapid radioimmunoassay for morphine and immunologically related substances in urine and serum.

Catlin D, Cleeland R, Grunberg E.

Clin Chem. 1973 Feb;19(2):216-20. No abstract available.

46.
48.

Alpha-chloromethyl-2-methyl-5-nitro-1-imidazoleethanol (Ro 7-0207), a substance exhibiting antiparasitic activity against amebae, trichomonads, and pinworms.

Grunberg E, Cleeland R, Prince HN, Titsworth E.

Proc Soc Exp Biol Med. 1970 Feb;133(2):490-2. No abstract available.

PMID:
4391835
49.

Efficiency of a multitest system (Enterotube) for rapid identification of Enterobacteriaceae.

Titsworth E, Grunberg E, Beskid G, Cleeland R Jr, Delorenzo WF.

Appl Microbiol. 1969 Aug;18(2):207-13.

50.

Automated technique for the detection of hemagglutinins to sheep erythrocytes.

Cleeland R, Grunberg E.

Appl Microbiol. 1969 May;17(5):726-33.

Supplemental Content

Loading ...
Support Center